Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments

Z Yuan, Y Li, S Zhang, X Wang, H Dou, X Yu, Z Zhang… - Molecular cancer, 2023 - Springer
The malignant tumor is a multi-etiological, systemic and complex disease characterized by
uncontrolled cell proliferation and distant metastasis. Anticancer treatments including …

[HTML][HTML] Nasopharyngeal carcinoma ecology theory: Cancer as multidimensional spatiotemporal “unity of ecology and evolution” pathological ecosystem

W Luo - Theranostics, 2023 - ncbi.nlm.nih.gov
Nasopharyngeal carcinoma (NPC) is a particular entity of head neck cancer that is generally
regarded as a genetic disease with diverse intertumor and intratumor heterogeneity. This …

Adjuvant therapy for stage II colon cancer: ASCO guideline update

NN Baxter, EB Kennedy, E Bergsland… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE To develop recommendations for adjuvant therapy for patients with resected
stage II colon cancer. METHODS ASCO convened an Expert Panel to conduct a systematic …

Pathological features and prognostication in colorectal cancer

K Chen, G Collins, H Wang, JWT Toh - Current Oncology, 2021 - mdpi.com
The prognostication of colorectal cancer (CRC) has traditionally relied on staging as defined
by the Union for International Cancer Control (UICC) and American Joint Committee on …

[HTML][HTML] Emerging roles of cystathionine β-synthase in various forms of cancer

K Ascenção, C Szabo - Redox biology, 2022 - Elsevier
The expression of the reverse transsulfuration enzyme cystathionine-β-synthase (CBS) is
markedly increased in many forms of cancer, including colorectal, ovarian, lung, breast and …

[HTML][HTML] Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) guideline

BLAM Weusten, R Bisschops, M Dinis-Ribeiro… - …, 2023 - thieme-connect.com
MR1 ESGE recommends the following standards for Barrett esophagus (BE) surveillance:–a
minimum of 1-minute inspection time per cm of BE length during a surveillance endoscopy …

Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models

M Li, Q **ao, N Venkatachalam… - Therapeutic …, 2022 - journals.sagepub.com
Colorectal cancer (CRC) is a major contributor to cancer-associated morbidity worldwide
and over one-third of CRC is located in the rectum. Neoadjuvant chemoradiotherapy (nCRT) …

Comparator data characteristics and testing procedures for the clinical performance evaluation of continuous glucose monitoring systems

M Eichenlaub, S Pleus, M Rothenbühler… - Diabetes technology …, 2024 - liebertpub.com
Comparing the performance of different continuous glucose monitoring (CGM) systems is
challenging due to the lack of comprehensive guidelines for clinical study design. In …

Personalizing adjuvant therapy for patients with colorectal cancer

L Yang, J Yang, A Kleppe, HE Danielsen… - Nature Reviews Clinical …, 2024 - nature.com
The current standard-of-care adjuvant treatment for patients with colorectal cancer (CRC)
comprises a fluoropyrimidine (5-fluorouracil or capecitabine) as a single agent or in …

Spatial structure governs the mode of tumour evolution

R Noble, D Burri, C Le Sueur, J Lemant… - Nature ecology & …, 2022 - nature.com
Characterizing the mode—the way, manner or pattern—of evolution in tumours is important
for clinical forecasting and optimizing cancer treatment. Sequencing studies have inferred …